260 related articles for article (PubMed ID: 29866846)
1. Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility.
Chen Z; Oh D; Biswas KH; Yu CH; Zaidel-Bar R; Groves JT
Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5696-E5705. PubMed ID: 29866846
[TBL] [Abstract][Full Text] [Related]
2. EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility.
Parri M; Buricchi F; Giannoni E; Grimaldi G; Mello T; Raugei G; Ramponi G; Chiarugi P
J Biol Chem; 2007 Jul; 282(27):19619-28. PubMed ID: 17449913
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases.
Baldwin C; Chen ZW; Bedirian A; Yokota N; Nasr SH; Rabb H; Lemay S
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F960-71. PubMed ID: 16735461
[TBL] [Abstract][Full Text] [Related]
4. Cell adhesion and EGFR activation regulate EphA2 expression in cancer.
Larsen AB; Stockhausen MT; Poulsen HS
Cell Signal; 2010 Apr; 22(4):636-44. PubMed ID: 19948216
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional signalling between EphA2 and ephrinA1 increases tubular cell attachment, laminin secretion and modulates erythropoietin expression after renal hypoxic injury.
Rodriguez S; Rudloff S; Koenig KF; Karthik S; Hoogewijs D; Huynh-Do U
Pflugers Arch; 2016 Aug; 468(8):1433-48. PubMed ID: 27228995
[TBL] [Abstract][Full Text] [Related]
6. EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase.
Parri M; Buricchi F; Taddei ML; Giannoni E; Raugei G; Ramponi G; Chiarugi P
J Biol Chem; 2005 Oct; 280(40):34008-18. PubMed ID: 16051609
[TBL] [Abstract][Full Text] [Related]
7. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).
Carter N; Nakamoto T; Hirai H; Hunter T
Nat Cell Biol; 2002 Aug; 4(8):565-73. PubMed ID: 12134157
[TBL] [Abstract][Full Text] [Related]
8. Redox regulation of ephrin/integrin cross-talk.
Buricchi F; Giannoni E; Grimaldi G; Parri M; Raugei G; Ramponi G; Chiarugi P
Cell Adh Migr; 2007; 1(1):33-42. PubMed ID: 19262085
[TBL] [Abstract][Full Text] [Related]
9. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
Wykosky J; Debinski W
Mol Cancer Res; 2008 Dec; 6(12):1795-806. PubMed ID: 19074825
[TBL] [Abstract][Full Text] [Related]
10. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.
Yang XY; Zhu WJ; Jiang H
Mol Cell Biochem; 2012 Feb; 361(1-2):259-65. PubMed ID: 22009484
[TBL] [Abstract][Full Text] [Related]
11. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.
Xu Q; Lin WC; Petit RS; Groves JT
Biophys J; 2011 Dec; 101(11):2731-9. PubMed ID: 22261062
[TBL] [Abstract][Full Text] [Related]
12. Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1.
Greene AC; Lord SJ; Tian A; Rhodes C; Kai H; Groves JT
Biophys J; 2014 May; 106(10):2196-205. PubMed ID: 24853748
[TBL] [Abstract][Full Text] [Related]
13. Tobacco smoke induces epithelial barrier dysfunction via receptor EphA2 signaling.
Nasreen N; Khodayari N; Sriram PS; Patel J; Mohammed KA
Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1154-66. PubMed ID: 24717580
[TBL] [Abstract][Full Text] [Related]
14. Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.
Tawadros T; Brown MD; Hart CA; Clarke NW
Br J Cancer; 2012 Nov; 107(10):1737-44. PubMed ID: 23037715
[TBL] [Abstract][Full Text] [Related]
15. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
Nasreen N; Mohammed KA; Lai Y; Antony VB
Cancer Lett; 2007 Dec; 258(2):215-22. PubMed ID: 17949899
[TBL] [Abstract][Full Text] [Related]
16. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.
Taddei ML; Parri M; Angelucci A; Onnis B; Bianchini F; Giannoni E; Raugei G; Calorini L; Rucci N; Teti A; Bologna M; Chiarugi P
Am J Pathol; 2009 Apr; 174(4):1492-503. PubMed ID: 19264906
[TBL] [Abstract][Full Text] [Related]
17. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.
Wykosky J; Palma E; Gibo DM; Ringler S; Turner CP; Debinski W
Oncogene; 2008 Dec; 27(58):7260-73. PubMed ID: 18794797
[TBL] [Abstract][Full Text] [Related]
18. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
Tandon M; Vemula SV; Sharma A; Ahi YS; Mittal S; Bangari DS; Mittal SK
J Gene Med; 2012 Feb; 14(2):77-89. PubMed ID: 22228563
[TBL] [Abstract][Full Text] [Related]
19. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.
Miao H; Burnett E; Kinch M; Simon E; Wang B
Nat Cell Biol; 2000 Feb; 2(2):62-9. PubMed ID: 10655584
[TBL] [Abstract][Full Text] [Related]
20. EphA2 promotes cell adhesion and spreading of monocyte and monocyte/macrophage cell lines on integrin ligand-coated surfaces.
Saeki N; Nishino S; Shimizu T; Ogawa K
Cell Adh Migr; 2015; 9(6):469-82. PubMed ID: 26565750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
